Novanta Inc
NOVT
Market Cap$5.6B
Close$
$49.72
68.8% downside
Current Fair Value
68.8% downsideOvervalued by 68.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.60 Billion |
|---|---|
| Enterprise Value | $5.85 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.02 |
| Beta | 0.0 |
| Outstanding Shares | 35,845,462 |
| Avg 30 Day Volume | 130,246 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 76.85 |
|---|---|
| PEG | -426.36 |
| Price to Sales | 6.64 |
| Price to Book Ratio | 8.86 |
| Enterprise Value to Revenue | 6.64 |
| Enterprise Value to EBIT | 47.48 |
| Enterprise Value to Net Income | 80 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.53 |
Revenue Sources
No data
ESG Score
No data
About Novanta Inc
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...